Detection of heterozygosity loss in microdissected fine needle aspiration specimens of breast carcinoma

Acta Cytologica

Volumn 40, Issue 4, 1996, Pages 642-648

  Chuaqui, Rodrigo ^a,b   Vargas, Perla ^a,b   Castiglioni, Teresa ^a,b,c   Elsner, Boris ^a,b,c   Zhuang, Zhengping ^a,b   Emmert Buck, Michael ^a,b   Merino, Maria J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CEMIC   (Argentina)

^c Center for Medical Education and Clinical Investigation   (Argentina)

Author keywords

Aspiration biopsy; Breast neoplasms; Heterozygosity

Indexed keywords

DNA MARKER;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CHROMOSOME 11Q; CHROMOSOME LOSS; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030014731     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333932     Document Type: Article

References (34)

1. Adye B, Jolly PC, Bauermeister DE: The role of fine-needle aspiration biopsy in the management of solid breast masses. Arch Surg 1988;123:37-39
2. Bell DA, Hajdu SI, Urban JA, Gaston JP: Role of aspiration cytology in the diagnosis and management of mammary lesions in office practice. Cancer 1983;51:1182-1189
3. Berg JW, Hutter RVP: Breast cancer. Cancer (suppl) 1995;75: 257-269
4. Berg JW, Robbins GF: A late look at the safety of aspiration biopsy. Cancer 1962;15:826-827
5. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377
6. Cady B: How to perform breast biopsies. Surg Oncol Clin North Am 1995;4:47-66
7. Callahan R: p53 Mutations, another breast cancer prognostic factor. J Natl Cancer Inst 1992;84:826-827
8. Devilee P, van Vliet M, van Sloun P, Dijkshoorn NK, Hermans J, Pearson PL, Cornelise CJ: Allelotype of human breast carcinoma: A second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991;6:1705-1711
9. Duda RB: Indications and Techniques of Breast Biopsy. In Treatment of Pre-Cancerous Lesions and Early Breast Cancer. Edited by IM Ariel, AC Cahan. Baltimore, Williams & Wilkins, 1993, pp 69-75
10. Eisenberg AJ, Hajdu SI, Wilhelmus J, Melamed MR, Kinne D: Preoperative aspiration cytology of breast tumors. Acta Cy-tol 1986;30:135-146
11. Frable WJ: Needle aspiration of the breast. Cancer 1984;53: 671-671
12. Greenebaum E, Koss LG, Sherman AB, Elequin F: Comparison of needle aspiration and solid biopsy techniques in the flow cytometric study of DNA distributions of surgically resected tumors, Am J Clin Pathol 1984;82:559-564
13. Halery A, Reif R, Bogokovsky H, Orda R: Diagnosis of carcinoma of the breast by fine-needle aspiration cytology. Surg Gynecol Obstet 1987;164:506-508
14. Hamptom GM, Mannerman A, Winquist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA: Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3. Cancer Res 1994;54:4586-4589
15. Iwasaki H, Stewart PW, Dilley WG, Holt MS, Steinbrueck TD, Wells S, Donis-Keller H: A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have a combined informativeness of PIC 0.95. Genomics 1992;13:7-15
16. Kline TS, Kannan V, Kline IK: Appraisal and cytomorpho-logic analysis of common carcinomas of the breast. Diagn Cytopathol 1985;1:188-193
17. Kline TS, Kline IK (editors): Guides to Clinical Aspiration Biopsy: Breast. New York, Igaku-Shoin, 1994
18. Kline TS, Lundy J, Lozowski M: Monoclonal antibody B72.3: An adjunct for evaluation of "suspicious" aspiration biopsy cytology from the breast. Caner (in press)
19. Levack PA, Mullen P, Anderson TJ, Miller WR, Forrest APM: DNA analysis of breast tumor fine needle aspirates using flow cytometry. Br J Cancer 1987;56:643-646
20. Ljung B-M, Chew K, Deng G, Matsumura K, Waldman F, Smith H: Fine needle aspiration techniques for the characterization of breast cancers. Cancer 1994;74:1000-1005
21. Lonn U, Nylen U, Stenkuist B, Vennstrom B: Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Res Treat 1992;23:191-200
22. Lundy J, Kline TS, Lozowski M, Chao S: Immunoperoxidase studies by monoclonal antibody B72.3 applied to breast aspirates: Diagnostic considerations. Diagn Cytopathol 1988; 4:95-98
23. Palombini L, Fulciniti F, Vetrani A, de Rosa G, di Benedetto G, Zeppa P, Troncone G: Fine-needle aspiration biopsies of breast masses: A critical analysis of 1956 cases in 8 years (1976-1984). Cancer 1988;61:2273-2277
24. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). NAR 1990;18:7468
25. Radford DM, Fair K, Thompson AM, Ritter JH, Holt M, Steinbrueck T, Wallace M, Wells SA Jr, Donis-Keller HR: Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 1993;53:2947-2950
26. Remvikos Y, Magoelenat H, Zajdela A: DNA flow cytometry applied to fine needle sampling of human breast cancer. Cancer 1988;61:1629-1634
27. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182
28. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712
29. Spyratos F, Briffold M, Gentile A, Brunet M, Brault C, Desplaces A: Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions. Ana-lyt Quant Cytol Histol 1987;9:485-494
30. Strawbridge HTG, Bassett AA, Foldes I: Role of cytology in management of lesions of the breast. Surg Gynecol Obstet 1981;152:1-7
31. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reih-saus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS: Accumulations of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-855
32. Venegas R, Rutgers JL, Cameron BL, Vargas H, Butler JA: Fine needle aspiration cytology of breast ductal carcinoma in situ. Acta Cytol 1994;38:136-139
33. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR: Allelic loss on chromosome 11q13 in in-situ and invasive sporadic breast cancer. Cancer Res 1995;55:467-471
34. Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D: Detection of the von Hippel-Lindau Disease gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. Acta Cytol 1994;38:671-675